Skip to main content
SpringerLink
Log in

PD-1-Antikörper

Eine neue Therapieoption beim metastasierten malignen Melanom

PD-1 Antibodies

A new therapeutic option for metastatic malignant melanoma

  • Journal Club
  • Published:
Der Hautarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Topalian SL, Hodi FS, Brahmer JR et al (2012) Safety, activity and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366:2443–2454

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehungen hin: Der Autor erhielt Berater- und Vortragshonorare von den Firmen Bristol-Myers Squibb und Roche.

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Dermatologie, Universität Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Deutschland

    C. Hafner

Authors
  1. C. Hafner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Hafner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hafner, C. PD-1-Antikörper. Hautarzt 63, 724–726 (2012). https://doi.org/10.1007/s00105-012-2433-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-012-2433-9

Search

Navigation